BioLoomics is Discovery Tools (Healthcare) in United States that focus on live-cell imaging business. Founded in 2019. They cover business area such as developer, biosensor technology, drug discovery, synthetic biology, live-cell imaging, high-throughput multiplexed profiling, biochemical event, mammalian cell, chemical library, complex mixture, bioactive nanoparticle, unique cellular response, their own hormone, client, drug development.
2019
( 5 years old in 2024 )
Live-cell Imaging
-
4665 Nautilus Court
Suite 501
Boulder, CO 80301
United States
Private
developerbiosensor technologydrug discoverysynthetic biologylive-cell imaginghigh-throughput multiplexed profilingbiochemical eventmammalian cellchemical librarycomplex mixturebioactive nanoparticleunique cellular responsetheir own hormoneclientdrug development
* We use standard office opening hours in near BioLoomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BioLoomics is Discovery Tools (Healthcare) business from United States that founded in 2019 (5 years old in 2024), BioLoomics business is focusing on Live-cell Imaging.
BioLoomics headquarter office and corporate office address is located in 4665 Nautilus Court Suite 501 Boulder, CO 80301 United States.
BioLoomics was founded in United States.
In 2024, BioLoomics is currently focus on live-cell imaging sector.
Above is snippet of Google Trends for "live-cell imaging" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BioLoomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
